# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-22-027008
Filing Date
2022-12-23
Accepted
2022-12-23 16:12:16
Documents
4
Period of Report
2023-02-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | rkda-pre14a_reversestock.htm | PRE 14A | 509956
2 | GRAPHIC | img226775617_0.jpg | GRAPHIC | 49571
3 | GRAPHIC | img226775617_1.jpg | GRAPHIC | 443973
4 | GRAPHIC | img226775617_2.jpg | GRAPHIC | 306001
| Complete submission text file | 0000950170-22-027008.txt |  | 1552975

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37383 | Film No.: 221485511
SIC: 0100 Agricultural Production-Crops